Trial Profile
Effect of plerixafor when given along with granulocyte colony stimulating factors on peripheral blood stem cell mobilization in patients with lymphoma and myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2015
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 02 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.